KRASHIA, PARASKEVI
 Distribuzione geografica
Continente #
AS - Asia 276
NA - Nord America 161
EU - Europa 144
SA - Sud America 2
AF - Africa 1
Totale 584
Nazione #
SG - Singapore 201
US - Stati Uniti d'America 158
IT - Italia 75
HK - Hong Kong 34
CN - Cina 31
GB - Regno Unito 31
NL - Olanda 14
DE - Germania 9
IN - India 4
UA - Ucraina 4
CA - Canada 3
FR - Francia 3
AT - Austria 2
PK - Pakistan 2
BR - Brasile 1
CL - Cile 1
FI - Finlandia 1
GR - Grecia 1
IE - Irlanda 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
SA - Arabia Saudita 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 584
Città #
Singapore 55
Boardman 36
Rome 36
Hong Kong 33
Ashburn 31
London 30
Milan 29
Shanghai 19
Santa Clara 18
Council Bluffs 10
Amsterdam 9
Buffalo 8
Los Angeles 6
Pune 4
San Francisco 4
Secaucus 4
Cave 3
Roubaix 3
Washington 3
Hanover 2
Nanjing 2
Redmond 2
Toronto 2
Xi'an 2
Yangzhou 2
Almere Stad 1
Bagheria 1
Bagnaria Arsa 1
Berlin 1
Bradford 1
Central 1
Changchun 1
Colombo 1
Dublin 1
Frankfurt am Main 1
Guangzhou 1
Hamburg 1
Helsinki 1
Heraklion 1
Kuala Lumpur 1
Luxembourg 1
Montreal 1
Nuremberg 1
Riga 1
Riyadh 1
São Paulo 1
Waldshut-Tiengen 1
Totale 375
Nome #
How dopamine tunes parvalbumin interneurons in the hippocampus: new experimental observations in Alzheimer's disease 36
Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model 34
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases 31
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease (Nature Communications, (2019), 10, 1, (3945), 10.1038/s41467-019-11928-w) 30
Dysfunctional dopaminergic neurotransmission in asocial BTBR mice 28
Chemogenetic rectification of the inhibitory tone onto hippocampal neurons reverts autistic-like traits and normalizes local expression of estrogen receptors in the Ambra1+/- mouse model of female autism 28
Agonist and blocking actions of choline and tetramethylammonium on human muscle acetylcholine receptors 27
Human α3β4 neuronal nicotinic receptors show different stoichiometry if they are expressed in Xenopus oocytes or mammalian HEK293 cells 27
Ambra1 shapes hippocampal inhibition/excitation balance: role in neurodevelopmental disorders 27
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 26
Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer's disease models 25
Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease 25
Hippocampal epileptogenesis in autoimmune encephalitis. 23
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease 23
Cisd2: a promising new target in Alzheimer's disease† 23
Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer's disease in Tg2576 mice 22
Incorporation of the β3 subunit has a dominant-negative effect on the function of recombinant central-type neuronal nicotinic receptors 21
The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease 21
Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer’s Disease 19
Neurodevelopmental Disorders: Functional Role of Ambra1 in Autism and Schizophrenia. 19
Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer’s Disease 18
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons. 17
Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease 16
On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area. 15
Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease. 15
The long activations of α2 glycine channels can be described by a mechanism with reaction intermediates ("flip") 14
Totale 610
Categoria #
all - tutte 7.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202230 0 0 0 0 0 0 1 8 2 0 0 19
2022/202379 0 0 54 3 3 0 0 0 1 0 18 0
2023/202490 4 11 6 12 5 44 0 0 4 2 0 2
2024/2025411 29 6 45 10 21 42 17 31 55 138 17 0
Totale 610